CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 8,600 shares, a growth of 65.4% from the March 15th total of 5,200 shares. Based on an average daily trading volume, of 55,100 shares, the short-interest ratio is currently 0.2 days.

CSL Stock Performance

OTCMKTS CSLLY opened at $91.49 on Friday. The stock’s 50-day simple moving average is $93.34 and its two-hundred day simple moving average is $89.09. CSL has a twelve month low of $71.51 and a twelve month high of $105.11.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.